0001104659-21-007671.txt : 20210126
0001104659-21-007671.hdr.sgml : 20210126
20210126163112
ACCESSION NUMBER: 0001104659-21-007671
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210125
FILED AS OF DATE: 20210126
DATE AS OF CHANGE: 20210126
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Edris Badreddin
CENTRAL INDEX KEY: 0001786966
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39044
FILM NUMBER: 21554472
MAIL ADDRESS:
STREET 1: C/O SPRINGWORKS THERAPEUTICS, INC.
STREET 2: 100 WASHINGTON BLVD.
CITY: STAMFORD
STATE: CT
ZIP: 06902
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SpringWorks Therapeutics, Inc.
CENTRAL INDEX KEY: 0001773427
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 WASHINGTON BOULEVARD
CITY: STAMFORD
STATE: CT
ZIP: 06902
BUSINESS PHONE: 203-883-9490
MAIL ADDRESS:
STREET 1: 100 WASHINGTON BOULEVARD
CITY: STAMFORD
STATE: CT
ZIP: 06902
4
1
tm214262-1_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2021-01-25
0
0001773427
SpringWorks Therapeutics, Inc.
SWTX
0001786966
Edris Badreddin
C/O SPRINGWORKS THERAPEUTICS, INC.
100 WASHINGTON BLVD.
STAMFORD
CT
06902
0
1
0
0
Chief Operating Officer
Common Stock
2021-01-25
4
S
0
32000
84.0713
D
261542
D
The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $81.76 to $89.00, inclusive
Includes 149,947 restricted stock awards subject to time-based vesting.
/s/ Francis I. Perier, Jr as Attorney-in-Fact
2021-01-26